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Abstract
Identification of clinical factors that can predict mortality and hospital early readmission in acute decompensated heart failure (ADHF)
patients can help emergency department (ED) physician optimize the care-path and resource utilization.
We conducted a retrospective observational study of 530 ADHF patients evaluated in the ED of an Italian academic hospital in 2013.
Median age was 82 years, females were 55%; 31.1% of patients were discharged directly from the ED (12.5% after short staying in
the observation unit), while 68.9%were admitted to a hospital ward (58.3% directly from the ED and 10.6% after a short observation).
At 30 days, readmission rate was 17.7% while crude mortality rate was 9.4%; this latter was higher in patients admitted to a hospital
ward in comparison to those who were discharged directly from the ED (12.6% vs. 2.4%, P< .001). Thirty-day mortality was
significantly related to older age, higher triage priority, lower mean blood pressure (MBP), and lower pulse oxygen saturation (POS). At
180 days, crude mortality rate was 23.2%, higher in admitted patients compared with discharged ones (29.6% vs. 9.1%, P< .001)
and was significantly related to older age, higher serum creatinine, and lower MBP and POS. At 12 and 22 months, crude mortality
rates resulted 30.4% and 45.1%, respectively.
Simple and objective parameters, such as age82 years, MBP> 104mmHg, POS>94%,may guide the ED physician to identify
low-risk patients who can be safely discharged directly from the emergency room or after observation unit stay.
Abbreviations: ACS = acute coronary syndrome, ADHF = acute decompensated heart failure, ASL = local health department,
BMI = body mass index, CI = confidence interval, COPD = chronic obstructive pulmonary disease, CRF = chronic renal failure, ED =
emergency department, EMR = electronic medical records, HF = heart failure, HR = hazard ratio, IQR = interquartile range, MBP =
mean blood pressure, OU = observation unit, POS = pulse oxygen saturation.
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risk stratification1. Introduction
Heart failure (HF) is a clinical syndrome typically manifesting
with fluid retention, dyspnea, and fatigue, which may limit
exercise tolerance.[1] In developed countries, HF affects approxi-
mately 1% to 2% of the adult population and >10% of the
elderly, thus represents a major, global public health challenge.[2]
Although our ability to manage HF has improved in the last fewEditor: Mazen El Sayed.
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1decades, recent data confirm that approximately 50% of HF
patients die within 5 years from diagnosis.[3]
HF course is often interspersed by episodes of acute
decompensated heart failure (ADHF), followed by worsening
of ventricular function. Symptoms of these patients accrue over
time, severely impairing function, and quality of life. ADHF
episodes prompt frequent emergency department (ED) accesses
and hospital admissions that may herald death, usually due to
pump failure or ventricular arrhythmia.[4] The early diagnosis
and the immediate start of the appropriate treatment are both
needed in the approach of ADHF patients in the ED.[5] However,
ED physicians face the additional challenge of identifying those
patients who need hospital admission from those who can be
safely discharged. In fact, unnecessary hospitalizations increase
costs and put the patients at risk of hospital-related complica-
tions, while inappropriate early discharges put patients at
increased risk of adverse outcomes.[6] ED observation units
(OUs) are an efficient tool to solve this conundrum.[7] As far as
the postdischarge event rates remain low,[8] diagnosis and
treatment of ADHF in OU is highly cost-effective, particularly for
those patients who require <24h care.[9] However, the difficulty
of discharging patients presenting with ADHF directly from the
ED is demonstrated by the wide variations observed in the direct
discharge rate in different countries, being low (16%) in the
United States,[10] intermediate (24–33%) in Spain,[11,12] and high
(36%) in Canada.[13] Unfortunately, information on this topic in
other countries, including Italy, is either scarce or lacking.
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term mortality of patients visiting the ED for ADHF, as well as
admission and discharge rates, ED revisit or hospital readmission
rates, and possible independent predictors of safe direct
discharge. To accomplish these tasks, we analyzed data of all
patients receiving an ED visit for ADHF in an Academic Hospital
of Northern Italy during solar 2013.2. Methods
2.1. Design and setting
This retrospective observational study was conducted in the
“AOU Maggiore della Carità” University General Hospital,
Novara, Italy. Data were obtained by interrogating the electronic
medical records (EMRs) of all patients visiting the ED between
January 1, 2013 and December 31, 2013. The index event was
defined as the first ED access due to HF in 2013. To identify HF
admissions, the International Classification of Diseases code
“428∗”[14] within the first 4 diagnosis positions and/or the
keyword “failure” for the verbatim of diagnosis entered by the
ED physician were used. This allowed us to select a cohort of 641
EMRs. In order to avoid selection bias, an expert ED physician
reviewed each individual EMR selected to confirm or exclude
ADHF in agreement with Framingham criteria.[15] We excluded
111 patients for whom ADHF was not considered the most
relevant clinical problem causing the ED access and/or for whom
data on follow-up could not be retrieved with certainty being they
resident outside the Novara Local Health Department (ASL NO)
area. This process led us to a final cohort of 530 patients. The
study was conducted according to the guidelines of the local
ethical committee and in conformity to the principles of the
Declaration of Helsinki.2.2. Data sources
Data were retrieved from EMRs, the Regional Register of
Piedmont, and the hospital data base of discharged patients.
The EMRs consulted (PSNET, Hitech spa, Firenze, Italy) contain
all personal and clinical data of EDpatients, includingEDoutcome
(i.e., short-term observation in OU, discharge at home, hospitali-
zation, or death). The Regional Register of Piedmont is a database
containing demographic and administrative data about the entire
resident population entitled to receive National Health Service
benefits in the Region. The discharge records database of the
“Maggiore della Carità” University General Hospital enables
retrieval of data on patients admitted to hospital ward, including
length of stay, in-hospital mortality, and final diagnosis.2.3. Demographic and clinical features of the patient
population
Demographic characteristics, clinical parameters at ED access,
triage color code, comorbidities, and ED outcome regarding the
index event were analyzed. Clinical parameters including mean
blood pressure (MBP), pulse oxygen saturation (POS) in room air
breathing, and heart rate were collected during triage. The triage
color code assigned by the triage nurses determined the visit
priority, a red tag meaning “need of immediate evaluation,” a
yellow tag “observation and possible later re-triage,” and a green
tag “wait.” Following the ED visit, the patients were either
discharged, admitted to the OU, or admitted to a hospital ward.
Time in the ED was calculated as hours from triage entry to ED2discharge. Serum creatinine concentration at the index event visit
was also collected.
Comorbidities were investigated taking into account both the
ED EMR and the discharge records from the hospital ward.
Specifically, we assessed the presence of the following conditions:
personal history of atrial fibrillation (all forms), previous episodes
of acute coronary syndrome (ACS), diabetes, hypertension,
chronic obstructive pulmonary disease (COPD), and chronic
renal failure (CRF). Obesity, evaluated through measurement of
body mass index (BMI), was defined as a BMI ≥30kg/m2.2.4. Outcomes
We determined the crude mortality rates at 30 days, 180 days, 12
months, and 22 months, being the censor date October 31, 2015.
Furthermore, we calculated the direct discharge rate from the ED,
as well as the OU transit and hospitalization rates, and measured
occurrence and timing of first ED revisits and/or first read-
missions to hospital wards after the index event.2.5. Statistical analysis
Statistical analysis of data was conducted using the Stata/IC
software package, rel. 13.1 (StataCorp LP, College Station, TX).
Throughout the paper, the measures of central tendency and
dispersion for continuous variables were medians and inter-
quartile ranges (IQRs), while differences among groups with
regard to these variables were tested either by theMann–Whitney
or the Kruskal–Wallis test, as appropriate. Categorical variables
were presented as frequencies (%), while associations between
themwere tested either by the Fisher exact test or the Pearson chi-
squared test, as appropriate. Survival times were calculated
starting on the day of the index event (first ED visit in solar
year 2013). The log-rank test was used to identify groups
with different survival probabilities, graphically presented in
Kaplan–Meier plots; hazard ratios (HRs) and relative 95%
confidence intervals (CIs) were also calculated. Finally, a Cox
proportional hazard model was built to analyze the weight of
predictors found at univariate analysis (we entered in the model
variables whose P value was< .10). The level of significance
chosen for all statistical tests was 0.05 (2-tailed).3. Results
3.1. Index event and patients’ disposal
The study population included 530 ADHF patients, of whom 290
were females (55%). The median age of the study population was
82 years (IQR 75–87). Women were significantly older than men
(84 years, IQR 79–88 vs. 80 years, IQR 73–85, P< .001). Table 1
summarizes demographic characteristics, clinical parameters, and
comorbidities of patients in the studied cohort, recorded at the
index event. In this regard, missing data were the following: MBP
for 16 patients,HR for 12 patients, POS for 16 patients, and serum
creatinine value for 5 patients. Out of 530 of patients, 365 (69%)
were admitted to a hospital ward; 56/365 patients (15.3% of
admitted patients and 10.6% of the whole cohort) a short stay at
the OU preceded hospital admission. Three-hundred nine patients
(84.7%of admitted patients and 58.3% of thewhole cohort) were
directly admitted to hospital ward after the ED evaluation. Out of
530 patients, 165 (31.1%) were discharged from ED either to be
sent home or to a long-term facility; 66/165 (40%or 12.5%of the
whole cohort) of patients who were discharged from the ED had
Table 1
Main demographic and clinical features of the study population.
Total (N=530) Admitted (N=365) Discharged (N=165) P
M/F 240 (45%)/290 (55%) 167 (46%)/198 (54%) 73 (44%)/92 (56%) .778
OU transit 122 (23%) 56 (15%) 66 (40%) <.001
Age, y 82 (75–87) 82 (75–87) 81 (75–87) .732
Triage color code <.001
Red 39 (7%) 37 (10%) 2 (1%)
Yellow 307 (58%) 249 (68%) 58 (35%)
Green 184 (35%) 79 (22%) 105 (64%)
Time in ED, h 5 (3–12) 5 (3–8) 9 (4–25) <.001
MBP, mm Hg 104 (92–117) 104 (93–117) 105 (92–117) .825
Heart rate, per min 85 (70–101) 87 (70–105) 80 (67–93) .002
POS 94 (89–96) 92 (88–96) 95 (92–97) <.001
Atrial fibrillation 254 (48%) 174 (48%) 80 (48%) .925
Previous ACS 176 (33%) 124 (34%) 52 (32%) .619
Hypertension 366 (69%) 243 (67%) 123 (75%) .069
Obesity 123 (23%) 83 (23%) 40 (24%) .739
Diabetes 173 (33%) 119 (33%) 54 (33%) 1.000
COPD 171 (32%) 116 (32%) 55 (33%) .764
CRF 129 (24%) 95 (26%) 34 (21%) .191
Creatinine, mg/dL 1.06 (0.82–1.48) 1.13 (0.84–1.56) 1.01 (0.80–1.32) .011
Data are presented for the whole population, patients admitted, and patients discharged from the ED. Continuous variables are presented as medians and interquartile range; categorical variables are presented as
frequencies (%). The P values refer to the comparison between admitted and discharged groups using the Wilcoxon rank-sum test, the Fisher exact test, or the Pearson chi-squared test, as appropriate. The
statistically significant P values are reported in bold.
ACS= acute coronary syndrome, COPD=chronic obstructive pulmonary disease, CRF= chronic renal failure, ED=emergency department, MBP=mean blood pressure, OU = observation unit, POS=pulse
oxygen saturation.
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the OU before being either admitted (N=56) or discharged (N=
66). Six of these 122 patients refused hospital admission. None of
the patients died in the ED.
Red and yellow tag patients were represented disproportion-
ately in the hospital admitted group in comparison to the
discharged group (10% vs. 1% and 68% vs. 35%, respectively,
P< .001 for both comparisons). Moreover, 22% of the admitted
patients had a green tag assigned at triage, in comparison to the
64% of patients that were subsequently discharged (P< .001).
Time in ED increased from a median of 5h (IQR 3–8) in the
admitted group up to 9h (IQR 4–25) in the discharged group
(P< .001). Creatinine value was higher in the admitted group
(1.13mg/dL vs. 1.01mg/dL, P= .011). MBP and comorbidities
did not differ in the 2 groups. Heart rate and POS were the only
vital signs with statistically significant differences in the 2 groups,
as reported in Table 1.
Kaplan–Meier plots, shown in Fig. 1, present survival
estimates at 30 days (A) and at the end of follow-up (B)
either among patients admitted to a hospital ward (N=365)
or among those discharged directly from ED after index visit
(N=165).
3.2. Early revisit and readmission rates
After 30 days from the index event, 17.7% of the patients
incurred in an ED revisit or a new hospital readmission. In the
revisited/readmitted group, heart rate at the index event was
significantly lower (80 bpm vs. 86 bpm, P= .042) while serum
creatinine was higher (1.18mg/dL vs. 1.02mg/dL, P= .028).
Among other variables, only previous ACS (44% vs. 31%,
P= .022) and CRF (33% vs. 22%, P= .035) were significantly
more prevalent in this group.33.3. Predictors of 30-day mortality
The crude 30-day mortality rate was 9.4% (N=50). The results
of the univariate analysis showed no differences in mortality
between males and females. Patients who died within 30 days
from the index event were older (median age 84 vs. 82, P< .001)
and had been more commonly assigned either to a red or yellow
triage color code. Moreover, MBP (98mm Hg vs. 105mm Hg,
P< .001) and POS (89% vs. 94%, P< .001) were lower while
creatinine (1.3mg/dL vs. 1.0mg/dL, P< .001) was higher in
patients who died early. Heart rate and time spent in ED did not
differ between the latter patients and survivors (see Table 2).
Analyzing patients based on triage color code, the 30-day
mortality rates were 23% for red tag patients, 10.4% for yellow
tag, and 4.9% for green tag. Moreover, splitting the data on
patients’ disposal (discharge vs. admission), we observed a 2.4%
30-day mortality rate for ED discharged patients and 12.6% for
admitted patients (P< .001).
Atrial fibrillation (30% vs. 50%, P= .011) and obesity
(10% vs. 25%, P= .021) were less represented among patients
who died within 30 days from the index event; hypertension
(56% vs. 70%, P= .052), and COPD (20% vs. 34%, P= .057)
had a similar trend, although statistical significance was
not reached.
The 30-day incidence rate of death varied from 3.73 per 1000
person-days (95% CI 2.82–4.93; N=49 events in 13,127 days) to
0.54 (95% CI 0.076–3.84, N=1 event in 1848 days) according to
the following 3 factors: age (cut-off value: 82 years), MBP (cut-off
value: 104mmHg), and POS (cut-off value: 94%). The correspond-
ing incidence ratio was 0.145 (95% CI 0.003–0.847, P= .006).
The Cox proportional hazard regression model (summarized
in Table 3) identified as independent predictors of 30-day
mortality age (HR=1.045), MBP (HR=0.959), POS (HR=
0.943), and a history of COPD (HR=0.417).
Figure 1. Kaplan–Meier survival estimates of being dead at 30 days (A) and at
the end of follow-up (B). Red lines indicate patients admitted to hospital after
the index visit at the ED, blue lines those discharged after the ED visit. Shaded
areas represent 95% confidence intervals. Numbers in parenthesis indicate
failures. ED = emergency department.
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The crude mortality rate at 180 days was 23.2% (N=123/530).
Again, splitting data on the bases of patients’ allocation, we
observed a 9.1% 180-day mortality rate for ED discharged
patients and 29.6% for admitted patients (P< .001).
Patients who died within 180 days from the index event were
older (83 years vs. 81 years, P< .001), but the triage color code
distribution did not differ between them and those who survived
beyond 180 days. Regarding MBP and POS, univariate analysis
showed lower values among patients dead at 180 days: 99mm
Hg vs. 107mm Hg (P< .001) and 91% vs. 94% (P= .004),
respectively. Creatinine was again higher among who died early
(1.3mg/dL vs. 1.0mg/dL, P< .001). Obesity resulted more
prevalent in survivors (15% vs. 26%, P= .01) while the other
comorbidities and the time spent in ED showed no differences
between the 2 groups (Table 2).
Age (HR=1.031), MBP (HR=0.979), POS (HR=0.957),
creatinine (HR=1.242), and history of hypertension (HR=
0.646) were significant independent predictors of death within
180 days after index event with Cox proportional hazard
regression model (Table 3).43.5. Long-term follow-up
After a minimum follow-up period of about 22 months (668
days), the total number of patients who died was N=239/530
(45.1%); 161 patients diedwithin the first year, leading to a crude
1-year mortality rate of 30.4%. In comparison to patients
discharged from ED after the index visit, the relative risk of being
dead for patients admitted to hospital was 5.6 (95%CI 2.0–15.4)
at 30 days, 3.8 (95% CI 2.2–6.6) at 180 days, 4.0 (95% CI
2.5–6.4) at 1 year, and 2.4 (95% CI 1.8–3.3) at the end of the
follow-up (see also Fig. 1B).4. Discussion
With the present study, we provide a contemporary snapshot of
patients accessing an ED for ADHF, of their disposal by ED
physicians, and of their outcomes shortly after the index event as
well as in the long term. At triage, age, POS, and MBP identify
patients with very low 30-day mortality. These findings will be
discussed at the light of the existing literature on the topic.
The first finding worth mentioning is that the median age in the
study population was 82 years, indicating that nowadays among
patients presenting to the ED with ADHF there are many
belonging to the “oldest old” category. Specifically, the
population in the present study was on average almost 10-year
older than those enrolled in other ED HF registries (i.e., 73 years
for ADHERE[16] and 72 years for ATTEND[17]). Likely, these
differences from previous studies stem from the combined effect
of the continuous ageing of the population (it should not be
forgotten that Italy has the second highest aging index among
European countries) and of the success in controlling factors
predisposing to HF, such as hypertension and coronary artery
disease. Despite the advanced age of patients, we observed a 30-
day crude mortality rate of 9.4%, similar to those observed in
other studies.[11,18] The 1-year crude mortality rate was 30.4% in
the entire cohort and rose to 38.6% considering only the patients
admitted to a hospital ward, again similar to the value observed
by Joffe et al in their analysis of in-hospital patients.[18] On the
other hand, among patients directly discharged from the ED, the
1-year mortality rate fell to 12.1%. This confirms the overall
correct risk stratification operated in the ED.
The median time spent in the ED was longer for patients who
were eventually discharged directly from the ED than for those
who were admitted to a hospital ward (in approximately 60% of
cases, an internal medicine division, data not shown). A
significantly larger proportion of patients who were directly
discharged from the ED had been managed in an OU, confirming
the clinical judgment of ED physicians that these patients were
more likely to improve quickly. The observation time allowed
them to treat the acute phase of HF, to verify the stability of the
patients, to optimize the therapy, to improve patient education,
and to arrange postdischarge care.[9,19,20]
The overall direct discharge rate from ED was 31.1%
(including those discharged after an OU stay), a value under
the target of 40%proposed byMirò et al for ED providedwith an
OU.[20] Nevertheless, the observed rate wasmarkedly higher than
the value previously reported in other countries (16% for the
United States[10] and 24% for Spain[11]). Moreover, the 30-day
revisit or hospital readmission rate observed in our study (17.7%)
was well below the target value of 20% suggested as quality
criteria.[20] Clinical history of previous ACS, renal function
impairment (both anamnestic CRF and creatinine higher value),
Table 2
Comparison of the characteristics of patients, categorized into different groups according to 30- and 180-day mortalities.
Dead at 30 d (N=50) Alive >30 d (N=480) P Dead at 180 d (N=123) Alive >180 d (N=407) P
M/F 28 (56%)/22 (44%) 212 (44%)/268 (56%) .135 58 (47%)/65 (53%) 182 (45%)/225 (55%) .680
Discharged/admitted 4 (8%)/46 (92%) 161 (34%)/319 (66%) <.001 15 (12%)/108 (88%) 150 (37%)/257 (63%) <.001
Age, y 84 (82–90) 82 (75–86) <.001 83 (80–89) 81 (74–86) <.001
Triage color code .001 .193
Red 9 (18%) 30 (6%) 13 (11%) 26 (6%)
Yellow 32 (64%) 275 (57%) 73 (59%) 234 (57%)
Green 9 (18%) 175 (36%) 37 (30%) 147 (36%)
Time in ED, h 5 (3–8) 5 (3–12.5) .324 5 (3–11) 6 (3–12) .437
MBP, mm Hg 98 (83–105) 105 (93–118) <.001 99 (87–110) 107 (94–120) <.001
Heart rate, per min 82 (66–105) 85 (70–101) .630 82 (66–100) 85 (70–102) .310
POS 89 (85–94) 94 (89–96) <.001 91 (86–96) 94 (89–96) .004
Atrial fibrillation 15 (30%) 239 (50%) .011 52 (42%) 202 (50%) .181
Previous ACS 17 (34%) 159 (33%) .876 44 (36%) 132 (32%) .513
Hypertension 28 (56%) 338 (70%) .052 77 (63%) 289 (71%) .095
Obesity 5 (10%) 118 (25%) .021 18 (15%) 105 (26%) .010
Diabetes 11 (22%) 162 (34%) .113 33 (27%) 140 (34%) .125
COPD 10 (20%) 161 (34%) .057 37 (30%) 134 (33%) .584
CRF 8 (10%) 121 (25%) .163 35 (28%) 94 (23%) .232
Creatinine, mg/dL 1.3 (1.1–1.7) 1.0 (0.8–1.5) <.001 1.3 (1.0–1.8) 1.0 (0.8–1.4) <.001
Continuous variables are presented as medians (interquartile range), and categorical variables are presented as frequencies (%). The P values refer to the comparison between the 2 groups at the Wilcoxon rank-
sum test, the Fisher exact test, or the Pearson chi-squared test, as appropriate. The statistically significant P values are reported in bold.
ACS= acute coronary syndrome, COPD= chronic obstructive pulmonary disease, CRF= chronic renal failure, ED= emergency department, MBP=mean blood pressure, POS=pulse oxygen saturation.
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or readmission.
Among vital signs, only reduced MBP and POS were related to
30-day mortality. The finding that a higher MBP in this setting
portends a favorable outcome in the short-term makes sense, and
is consistent with evidence indicating that in ADHF hypotension
associated with increased mortality.[21] POS is known to be a
reliable indicator of arterial blood oxygen concentration,[22] and
may usefully contribute to the assessment of both diagnosis and
prognosis in ADHF due to myocardial infarction.[23] Our data
confirm and strengthen the prognostic role of POS for patients
presenting with ADHF and this was confirmed even selectingTable 3
Cox proportional hazard regression model of factors associated wit
Factor Hazard ratio
30 d Hypertension
∗
0565
Obesity
∗
0.474
COPD
∗
0.417
Age† 1.045
MBP† 0.959
POS† 0.943
Creatinine† 1.184
Triage color code‡ 0.586
180 d Hypertension
∗
0.646
Obesity
∗
0.668
Age† 1.031
MBP† 0.979
POS† 0.957
Creatinine† 1.242
This table shows the hazard ratios resulted from multivariate analysis. Variables were selected if their P value
reported in bold.
COPD= chronic obstructive pulmonary disease, MBP=mean blood pressure, POS=pulse oxygen satur
∗
Categorical variables.
† Continuous numerical variables.
‡ Ordinal variables (red 1; yellow 2, and green 3).
5patients on the base of the presence or not of a clinical history of
COPD (data not shown). This may have relevant clinical
implications, helping physician to identify patients at high risk
on which hospital resources need to be directed, and providing
the rationale for stricter follow-up.
An unexpected finding in our study was the protective role
attributed to comorbidities, such as obesity and atrial fibrillation
(P< .05), but lightly also for hypertension and COPD (P< .10) at
the univariate analysis of factors associated with 30-day
mortality. This apparent paradox was confirmed at multivariate
analysis only for COPD at 30 days and for arterial hypertension
when 180 days follow-up time was considered. However, ourh 30- and 180-day mortality.
95% Confidence interval P
0.303 1.05 .072
0.185 1.217 .121
0.195 0.896 .025
1.010 1.081 .012
0.942 0.976 <.001
0.902 0.987 .011
0.979 1.434 .082
0.304 1.129 .110
0.436 0.959 .030
0.400 1.118 .125
1.009 1.054 .005
0.969 0.990 <.001
0.931 0.983 .001
1.096 1.408 .001
s at univariate analysis of 30- and 180-day mortality was<.10. The statistically significant P values are
ation.
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study from the United States, in which in-hospital death rates for
patients with and without COPD were similar, whereas the 5-
year survival rate of ADHF was 40% worse for patients with
concomitant COPD.[24] It might be noted, in turn, that the 2
studies share the observation that COPD is not a negative
prognostic factor for short-term survival of patients presenting
with ADHF. It could be speculated that COPD exacerbations (by
definition, a confounder in this setting) may bring the patient with
HF to the hospital, but may also benefit from short-term
measures such as antibiotic therapy with comparatively better
survival, and that, generally speaking, control of comorbidities
and better nutritional status may positively affect survival of
ADHF in the short-term. Furthermore, part of the differences
between the 2 studies may be explained considering that both are
limited by the inability of quantifying the severity of COPD, likely
a major factor influencing the extent to which the latter condition
influences survival of ADHF patients.
Impaired renal function is a well-documented predictor of in-
hospital and postdischarge mortality in patients with
ADHF.[25–27] Less data are available about its role in ED’s
cohorts and about identifying low-risk patients, and that is a field
on which further analysis are being carried out. For instance the
score EHMRG proposed by Lee et al, which contains creatinine
among its variable, it is used to predict 7-day mortality after ED
visit.[28]
Our data, based on the evaluation of serum creatinine
concentration during the index event, allowed us to confirm
previously reported data since increased creatinine concentration
resulted an independent predictor of 180-day mortality. Plasma
creatinine concentration resulted significantly associated with
hospitalization and 30-day mortality at univariate analysis but
this significance was not confirmed in multivariate analysis using
Cox proportional hazard model. In other words, plasma
creatinine proved to be an important independent predictor of
mortality at mid-term, less so at short-term.
Mortality at 30 days, 180 days, 12months, and 22months was
significantly and consistently better among patients who were
directly discharged from ED after the index event than among
patients admitted to a hospital ward. Therefore, the judgment
made by ED physicians on clinical grounds proved to be correct.
Patients aged 82 years or less, who had an MBP >104mm Hg
and a POS >94% had very low 30-day incidence death rates.
Interestingly, POS was significantly lower among patients who
were admitted to a hospital ward after the ED visit, while MBP
and age were not. In theory, a putative rule of thumb including all
3 the above-mentioned parameters may improve the clinical
decisionmaking of ED physicians, for example encouraging them
to pursue ADHFmanagement in OU, which may further increase
the direct discharge rate.4.1. Study limitations
The major limitations of our study stem from his retrospective
design. Selection bias could represent a problem; even if we tried
to reduce it (e.g., using validation by ED expert), it is possible that
this has not been completely eliminated. Moreover, we had to
deal with some missing data for a few variables used in our
analysis and we have not been able to collect other variables that
could have been of interest (specifically, BNP and ejection
fraction). We also had the possibility to assess only mortality
from any cause and not the mortality for specific causes such as
HF and related conditions; the same is true for ED revisits and6readmissions. A prospective cohort study would avoid these
biases and limitations and might validate our results.5. Conclusions
Direct discharge rates from the ED of patients presenting with
ADHF remain below the ideal 40% threshold, although they are
approaching it. Simple vital parameters routinely obtained at
triage, such as MBP and POS, may identify—in the ageing
population typically affected by ADHF in developed countries—
those patients who may benefit of focused care in OU, aimed to
rapid improvement and direct discharge from the ED, with
considerable savings.References
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